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Specific lipid-mobilizing peptide fractions had been 
earlier prepared from the pituitaries of various animal 
species [l-3]. In homogeneous form, however, only 
&lipotropin (&LPH) (sheep [4], bovine [5], pig [6]) 
and y-lipotropin (sheep [7]) were isolated. Human 
pituitaries were also shown to contain lipolytic agents 
of biological specificity, but isolation of such substan- 
ces in high purity [8--l I] and chemical characteriza- 
tion, respectively [ 121, have not yet been carried out. 
Here we want to report on the isolation and proper- 
ties of a human pituitary peptide which resembles the 
@-LPH mentioned in both chemical and biological res- 
pect. 
Pituitaries removed from cadavers were collected in 
cold acetone. As the first step, 600 whole glands were 
extracted at OOC, after homogenization, with 3.0 I acid 
acetone including the amounts of acetone used for 
immersion after the autopsy. (The acetone concentra- 
tion was made up to 65 per cent containing 0.35 N 
hydrochloric acid.) The preparative steps following 
next were identical with those in the procedure of Li 
et al. [4] for the isolation of fraction D’. Chromato- 
graphy of the fraction D’ on carboxymethyl-cellulose 
(CMC) is shown in fig. 1. Of the two fractions found 
to be the most active on rabbit adipose tissue, fraction 
4, lacking of adrenocorticotropic activity, was re- 
chromatographed on carboxymethyl-(CM) Sephadex 
(C-25) column (fig. 2). It can be seen that the lipo- 
lytic activity is concentrated in a small peak. Our ob- 
servations have shown the quantity of the active com- 
ponent to decrease progressively during the prepara- 
tive steps and rechromatography (the column chrom- 
atographic separations were conducted at room tem- 
perature). The first peak obtained from the CM-Sepha- 
dex column is also assumed to contain peptides under- 
gone alteration during two consecutive separation 
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steps (e.g. oxidized methionine residues). The poly- 
acrylamide-gel electropherogram of the retarded ac- 
tive component is shown in fig. 3, compared with 
the starting fraction D’. This active peptide proved to 
be homogeneous also according to electrophoresis in 
acid medium. Its yield from 600 pituitaries in lyophil- 
ized state amounted to 3.5 mg. When run on a G-50 
or G-75 Sephadex Superfine layer in 0.1 N acetic 
acid and 0.05 M ammonium carbonate, respectively, 
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Fig. 1. Chromatography of 950 mg human pituitary concen- 
trate, fraction D’ on CM-cellulose column (60 cm X 2.2 cm); 
5 ml per tube; flow rate 60 ml/hour. The column was initial- 
ly equilibrated with 0.01 M ammonium acetate, pH 4.6. 
After placing the material on the column a gradient elution 
was performed by introducing 0.1 M ammonium acetate, pH 
6.7 through a 500 ml mixing flask containing the starting buf- 
fer. At tube 150 0.2 M ammonium acetate, pH 6.7 was sub- 
stituted as the buffer flowed through the mixing flask. 
Tubes belonging to particular fractions were pooled and 
lyophilized. The solid line (left ordinate) shows the absor- 
bance of the effluent at 280 nm, and the dashed line the 
lipolytic activities of each fraction as measured in vitro on 
rabbit adipose tissue at a peptide concentration 1 ,ug/ml and 
expressed as peq FFA1g.h. 
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Fig. 2. Chromatography of 20 mg of peak 4 obtained from 
CM-cellulose column on CM-Sephadex column (50 cm X 1 cm), 
initially equilibrated with 0.05 M ammonium acetate, pH 5.5. 
Elution was performed by introducing 0.2 M ammonium ace- 
tate buffer, pH 7.0 through 500 ml mixing flask, containing 
starting buffer. The dashed line (right ordinate) shows the 
amounts of FFA liberated during 1 hour from 1 g rabbit adipose 
tissue by 0.1 fig of each ly ophilized fraction. 
it was subject to a retention equal to that of pig PLPH 
(for the procedure see Morris [ 131). The molecular 
weight of the pig PLPH was shown to be about 11,000 
in the sedimentation analysis [6] . Taken into consider- 
ation this value and the Try/Tyr ratio 1: 3 its amino 
acid composition is assumed to be as follows: Lysg 
His2 Arg5 Asp6 Thr4 Serg Glu,, Pro6 Glyll Alaa Val, 
Met2 Ileu, Leua Tyr3 Phe, TryI. (The amino acid 
analysis was performed by a Unichrom Autoanalyzer in 
Dr. Devenyi’s Laboratory, Biochemical Institute, Hun- 
garian Academy of Sciences, Budapest.) 
Its lipolytic activity on rabbit retroperitoneal adi- 
pose tissue in Krebs-Ringer medium (phosphate) was 
shown to be 5 X 1 0e3 lug as given by the minimal effec- 
tive dose, while that of pig ACTA (Ferring, 84s.~. 
Sayers U/mg) was 4 X 10e3 pg. Under similar circum- 
stances it did not display any activity at levels less 
than 10 I-(g on rat epididymal adipose tissue. Its mini- 
mal effective dose on human subcutaneous adipose 
tissue (surgical specimens) when measured in Krebs- 
Ringer medium (bicarbonate) containing 5% human al- 
bumin proved to be 1 X 10-l pg. When administered 
intravenously to rabbits at a dose of 10 E.cg/kg, it in- 
creased the plasma free fatty acid level within 30 min 
from 400 to 1150 peq/ 1. (Tested by Dr. G.Tamasi, Re- 
search Institute for Pharmaceutical Chemistry, Buda- 
pest.) Its in uivo steroidogenic activity [ 141 was 0.02 
Fig. 3. Disc electrophoresis in 10 per cent gel of human D’ 
fraction (left) and the purified lipotropin (right) obtained 
from the CM-Sephadex column. 150 r.rg and 50 pg, respective- 
ly, amounts of substances were polymerized in the sample 
gel. The electrophoresis was performed at pH 8.5 using a 
potential gradient 50 V/cm for 25 min. Migration toward 
anode. 
IU/mg. (Measured by Dr. G.Hajos, G.Richter Ltd., 
Budapest.) The prolactin activity amounted no more 
than 0.05 IU/mg. (Data from Dr. M.Kurcz, National 
Institute of Health, Budapest.) 
This newly isolated peptide is apparently different 
from the DLMF-1 peptide of Trygstad recently de- 
scribed [ 121 , both in its molecular weight and lipo- 
lytic activity on rabbit and human adipose tissue, 
respectively, in vitro. On the other hand, it may be 
considered as a human analogue of p-LPH on the 
basis of its isolation behaviour, molecular size, electro- 
phoretic mobility and effects on adipose tissue of 
43 
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various species. The lipolytic activity of this peptide on [4] C.H.Li, L.Barnati, M.Chrdtien and D.Chung, Nature 
human adipose tissue exceeds that of pig &LPH [ 151. 208 (1965) 1093. 
Further investigations are in progress to decide to 
which sites in the polypeptide chain can be assigned 
the differences found in amino acid composition as op- 
posed to animal LPH’s, furthermore, which role can 
be attributed to these differences in the species specifi- 
city of the biological action. 
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